Bladder Cancer

Radiogenomic analysis of muscle-invasive bladder cancer using CT-based texture analysis. June 3, 2026

Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Randomized Phase II Study of Two Alternative Dosing Schedules. June 2, 2026

Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial. June 2, 2026

Unmet Treatment Need and Challenges Associated with Comparative Evidence Generation in BCG-unresponsive Non-muscle-invasive Bladder Cancer: An Expert Consensus. June 1, 2026

Durvalumab and BCG Approved for Treating High-Risk NMIBC May 29, 2026

Computed tomography-derived extracellular volume fraction is associated with high-grade recurrence in non-muscle-invasive bladder cancer treated with intravesical gemcitabine and docetaxel. May 29, 2026

Trends in the diagnosis of variant bladder cancer: a national retrospective cohort analysis. May 28, 2026

Diagnostic performance of urinary tumor DNA in urothelial carcinoma: A systematic review and network meta-analysis. May 27, 2026

Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical Surgery. May 26, 2026

Outcomes for females versus males treated with eribulin mesylate for advanced urothelial carcinoma. May 26, 2026

Evolution of treatment and oncological outcomes in patients undergoing radical cystectomy: a comparative analysis across two decades at a tertiary center. June 3, 2026

What's next for VI-RADS? Updates and future perspectives from the ACR VI-RADS steering committee. June 2, 2026

AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy. June 1, 2026

Decoding Immune Mechanisms in BCG-unresponsive Non-muscle Invasive Bladder Cancer. June 1, 2026

Real-world Patterns and Trends of Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer: Insights from a Large Prospective German Cohort. May 29, 2026

Proceedings of the first international NMIBC consensus classification meeting. May 28, 2026

Effective PD-1 checkpoint blockade in bladder cancer model requires tumor-draining lymph nodes and lymphocyte trafficking. May 27, 2026

Detection of Bladder Cancer in Patients with Microscopic Hematuria Using Oncuria-Detect: Results of a Prospective, Multicenter International Study - Beyond the Abstract May 26, 2026

Artificial Intelligence Remote Patient Monitoring for Predicting Overall Survival for Patients Undergoing Radical Cystectomy for Bladder Cancer: Exploratory Analysis of the Prospective Trial. May 26, 2026

Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder Cancer. May 25, 2026

Page 1 of 602